Comparative in vitro activity of A-56268
- 1 December 1988
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 7 (6) , 798-802
- https://doi.org/10.1007/bf01975054
Abstract
The comparative in vitro activity of A-56268 was studied using 1,006 clinical isolates including streptococci, enterococci, staphylocci,Neisseria gonorrhoeae, Haemophilus influenzae and anaerobes. A-56268 showed activity comparable to that of erythromycin and was more active than josamycin and roxithromycin against erythromycin-sensitive aerobic and facultatively anaerobic gram-positive cocci. A-56268 was the most active macrolide againstClostridium spp. andNeisseria gonorrhoeae. Josamycin was more active than either A-56268 or erythromycin against the anaerobic gram-positive cocci and theBacteroides fragilis group. Staphylococci moderately resistant or resistant to erythromycin (MIC 3.12–50 mg/l) remained susceptible to josamycin but not the other macrolides.This publication has 11 references indexed in Scilit:
- Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1987
- Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibioticEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative pharmacokinetics of macrolidesJournal of Antimicrobial Chemotherapy, 1987
- In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolideAntimicrobial Agents and Chemotherapy, 1986
- Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogsJournal of Antimicrobial Chemotherapy, 1986
- Erythromycin stearate, 1∣5 g, for the oral prophylaxis of streptococcal bacteraemia in patients undergoing dental extraction: efficacy and toleranceJournal of Antimicrobial Chemotherapy, 1985
- CLINICAL MULTICENTER TRIAL WITH JOSAMYCIN PROPIONATE IN PEDIATRIC-PATIENTS1984
- [Hepatitis caused by various derivatives of erythromycin].1983
- Gastrointestinal Tract Symptoms From Intravenously Administered ErythromycinPublished by American Medical Association (AMA) ,1982
- The estimation of the bactericidal power of the bloodEpidemiology and Infection, 1938